Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya® (PASSOS)
The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders.
Frequency analysis approach to study balance control in individuals with multiple sclerosis.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test
Cell-Based Reporter Gene Assay for Therapy-Induced Neutralizing Antibodies to Interferon-Beta in Multiple Sclerosis.
Does the immune system act as a self-organized system in multiple sclerosis?
Neuroprotection and repair in multiple sclerosis.
Multiple sclerosis severity and concern about falling: Physical, cognitive and psychological mediating factors.
Neuromyelitis optica spectrum disorder and varicella-zoster infection.
Intrathecal CD4(+) and CD8(+) T cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
Design and development of an ethnically-diverse imaging informatics-based eFolder system for multiple sclerosis patients.
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.
Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies.
You're the Flight Surgeon.
The formation of inflammatory demyelinated lesions in cerebral white matter.
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.
Prevalence of Sexual Dysfunctions Among Women with Multiple Sclerosis.
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
Vitamin d assays: past and present debates, difficulties, and developments.
Clinical outcomes in multiple sclerosis patients following venous angioplasty.
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation.
Preliminary results after upper cervical chiropractic care in patients with chronic cerebro-spinal venous insufficiency and multiple sclerosis.
Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge.
Multiple measures of corticospinal excitability are associated with clinical features of multiple sclerosis.
Pages
« first
‹ previous
…
408
409
410
411
412
413
414
415
416
…
next ›
last »